Division of Nephrology, Department of Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Perit Dial Int. 2010 Mar-Apr;30(2):170-7. doi: 10.3747/pdi.2008.00277. Epub 2010 Feb 1.
Peritoneal dialysis (PD) technique failure is high compared to hemodialysis (HD). There is a lack of data on the impact of duration of PD treatment on technique survival and on whether there is a difference in risk factors with respect to early and late failure. The aim of this study was to clarify these issues by performing a time-dependent analysis of PD technique and patient survival in a large cohort of incident PD patients.
We analyzed 709 incident PD patients participating in the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD), who started their treatment between 1997 and 2007. We compared technique and patient survival on PD in 4 periods of follow-up: within the first 3 months, and after 3 - 12 months, 12 - 24 months, and 24 - 36 months of treatment. Cox proportional hazards model was used to analyze survival on PD and technique failure. Risk factors were also identified by comparing patients that were transferred to HD with those that remained on PD. Incidence rates for every cause of dropout for each period of follow-up were calculated to establish their trends with respect to PD treatment duration.
There was a significant increase in transplantation rate after the first year of treatment. The rate of switching to HD was highest during the first 3 months and decreased afterward. One-, 2- and 3-year technique survival was 87%, 76%, and 66%, respectively. Age, diabetes, and cardiovascular disease appeared to be risk factors for death on PD or switch to HD: a 1-year increase in age was associated with a relative risk (RR) of PD failure of 1.04 [95% confidence interval (CI) 1.003 - 1.06]; for diabetes, RR of stopping PD after 3 months of treatment increased from 1.8 (95% CI 1.1 - 3) during the first year to 2.2 (95% CI 1.3 - 4) after the second year; cardiovascular disease had a major impact in the earliest period (RR 2.5, 95% CI 1.2 - 5) and had a stable influence further on (RR 2, 95% CI 1.1 - 3.5). Loss of 1 mL/minute residual glomerular filtration rate (rGFR) appeared to be a significant predictor of PD failure after 3 months of treatment, but within the first 2 years, RR was 1.1 (95% CI 1.04 - 1.25).
In The Netherlands, transplantation is a main reason to stop PD treatment. The incidence of PD technique failure is at its highest during the earliest months after treatment initiation and decreases later due to fewer catheter and abdominal complications as well as less influence of psychosocial factors. Risk factors for PD discontinuation are those responsible for patient survival: age, cardiovascular disease, diabetes, and rGFR.
与血液透析(HD)相比,腹膜透析(PD)技术失败率较高。关于 PD 治疗持续时间对技术生存率的影响,以及早期和晚期失败的风险因素是否存在差异,目前数据有限。本研究旨在通过对大量新开始 PD 治疗的患者进行时间依赖性 PD 技术和患者生存率分析来阐明这些问题。
我们分析了参加荷兰透析充分性合作研究(NECOSAD)的 709 例新开始 PD 患者,他们于 1997 年至 2007 年间开始治疗。我们比较了 4 个随访期内 PD 技术和患者生存率:治疗的最初 3 个月内,3-12 个月,12-24 个月和 24-36 个月。使用 Cox 比例风险模型分析 PD 治疗和技术失败的生存率。通过比较转为 HD 的患者与仍在 PD 治疗的患者,还确定了风险因素。为了确定每个随访期 PD 治疗持续时间的趋势,计算了每种原因退出的发生率。
治疗后第一年,移植率显著增加。在最初的 3 个月内,转为 HD 的比例最高,此后逐渐下降。1、2 和 3 年的技术生存率分别为 87%、76%和 66%。年龄、糖尿病和心血管疾病似乎是 PD 死亡或转为 HD 的风险因素:年龄每增加 1 岁,PD 治疗失败的相对风险(RR)为 1.04[95%置信区间(CI)1.003-1.06];在治疗的最初 3 个月内,糖尿病患者停止 PD 治疗的 RR 从 1.8(95%CI 1.1-3)增加到第二年的 2.2(95%CI 1.3-4);心血管疾病在最早的时期有较大的影响(RR 2.5,95%CI 1.2-5),随后稳定影响(RR 2,95%CI 1.1-3.5)。治疗后 3 个月内,残余肾小球滤过率(rGFR)降低 1 毫升/分钟似乎是 PD 治疗失败的一个重要预测因素,但在前 2 年内,RR 为 1.1(95%CI 1.04-1.25)。
在荷兰,移植是停止 PD 治疗的主要原因。PD 技术失败的发生率在治疗开始后的最初几个月最高,随着导管和腹部并发症的减少以及心理社会因素的影响降低,失败率会降低。停止 PD 治疗的风险因素是导致患者死亡的因素:年龄、心血管疾病、糖尿病和 rGFR。